XDAP (Innovator U.S. Equity Accelerated ETF – April) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

The fund invests at least 80% of its net assets in a portfolio of FLexible EXchange® Options that reference the SPDR® S&P 500® ETF Trust, an exchange-traded fund registered under the Investment Company Act of 1940. FLEX Options are exchange-traded options contracts with uniquely customizable terms. Although guaranteed for settlement by the Options Clearing Corporation, FLEX Options are still subject to counterparty risk with the OCC and may be less liquid than more traditional exchange-traded options. It is non-diversified.
Is XDAP's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Wall Street was moderately upbeat last week.

CHICAGO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Innovator Capital Management , LLC (Innovator), pioneer and provider of the largest lineup of Defined Outcome ETFs™, today announced its intention to close four ETFs. Please reference the table below for important dates surrounding the closure of each ETF.

Buffer exchange traded fund strategies can help investors remain fully invested in the markets up to a cap, with built-in buffers to help manage downside risks. In the recent webcast, How to Stay Invested While Seeking to Buffer Against Risk In 2022, Innovator ETFs' co-founder and CEO, Bruce Bond, warned that there are no shortage [.

Faced with the prospect of lower returns, many investors could be looking for ways to enhance their upside, but some traditional leveraged funds can mean shouldering added risk. However, a new class of ETFs offers investors the potential to magnify equity gains 2x or 3x, up to a cap, without magnifying their downside exposure at [.